Plant-derived natural products against hepatocellular carcinoma: chemical diversity, mechanisms of action, and organ-based classification.
Liver cancer, particularly hepatocellular carcinoma (HCC), remains a major global health burden due to late diagnosis, limited therapeutic options, and frequent resistance to drugs such as sorafenib, regorafenib, and lenvatinib. Natural products continue to attract attention as a rich source of structurally diverse ant...